Lead Product(s) : GEN1042
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : Genmab
Deal Size : Undisclosed
Deal Type : Collaboration
InSys Bio Announces Its Collaboration with Genmab
Details : Genmab together with BioNTech, has begun clinical development of an investigational therapy, GEN1042 (DuoBody®-CD40x4-1BB), for solid tumors. GEN1042 is a novel bispecific agonistic antibody targeting CD40 and 4-1BB for priming and activation of tumor-s...
Product Name : GEN1042
Product Type : Antibody
Upfront Cash : Undisclosed
September 23, 2020
Lead Product(s) : GEN1042
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : Genmab
Deal Size : Undisclosed
Deal Type : Collaboration